CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −1,953 | 3,906 | ||
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,604 | 36,458 | ||
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −18,749 | 131,261 | ||
| 2018-11-12 | THERO JOHN F President and CEO | Option exercise | +407,611 | $1.35 | $550K | 2,702,139 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −136,422 | $18.05 | $2.5M | 2,565,717 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −244,031 | $19.03 | $4.6M | 2,321,686 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −222,158 | $19.71 | $4.4M | 2,099,528 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −5,000 | $20.72 | $104K | 2,094,528 |
| 2018-11-12 | THERO JOHN F President and CEO | Option exercise · Stock Option (Right to Buy) | −407,611 | 0 | ||
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 343,901 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 348,068 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 351,818 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 355,568 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 358,339 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Sale | −16,542 | $20.72 | $343K | 341,797 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Sale | −500 | $21.39 | $11K | 341,297 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 39,062 | ||
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 33,332 | ||
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 30,000 | ||
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option | −3,750 | 60,438 |
Page 79 of 95 · 1,885 trades